Who are we?
We are a young, innovative, research-led company that designs, develops and creates novel solutions to tissue culture limitations to meet your research needs.
What is our Company Mission?
The Company’s mission is to provide bespoke products that allow our customers to fully exploit the in-vitro culture of cells in applications related to regenerative medicine, diseases such as cancer and diabetes, in-vitro drug screening and for incorporation into bioinks.
What is different about our products?
- Our PhenoDrive products promote the formation of 3D cell spheroids from 2D culture systems without need for gels.
- PhenoDrives are animal component free and are provided as lyophilised powders that are easily reconstituted and incorporated into your existing protocols.
- PhenoDrives are a range of fully synthetic, biomimetic materials to provide simple, single step solutions to promote your cell culture models and preserve phenotype through mimicry of the extra cellular matrix.
- Nanosperse allows the simple dispersal of nanoparticles for individual testing and study
Where are we based?
We are based in the city of Brighton and Hove, East Sussex, England
Funded By
Horizon 2020 research and innovation programme.
The EU project MEFISTO is taking on the challenge of developing innovative ways of using bioactive functionalised materials to prevent the onset of osteoarthritis following meniscus loss. Tissue Click Ltd is providing the bioactive mimics to manipulate the cells surrounding the implants to modify their behaviour. https://www.mefisto-project.eu
Funded By
Innovate UK, the UK’s innovation agency.
Along with its European partner the University of Salerno, we are developing a kit for the sensitive, rapid and inexpensive diagnosis of Covid-19 infection. The project has been co-funded by Innovate UK, under the competitive funding scheme UKRI Open call for research and innovation ideas to address COVID-19.
Funded By
Horizon 2020 Large-scale research initiative programme
The RESTORE project is a comprehensive 10 year programme to increase the awareness of advanced therapies to the European Commission, European Parliament, scientific community, patient advocates and the public.
Funded By
Horizon 2020 European Funding for Research & Innovation
Along with three other partners we are working on the CENSUS project which is working towards providing a technical solution for neurodegenerative disorders. The project will produce CNS cell models from a consistent, renewable source, in the form of induced pluripotent stem cells (iPSC); will manufacture 3D scaffolds in multiwell culture plates by micro-extrusion technology.
Our Key Team
Discover the TissueClick staff credentials
Dr. Guildford is the Technology Exploitation Manager at Tissue Click Ltd. Anna has over 20 years of experience in the field of cell biology, tissue engineering and regeneration. She joined Tissue Click Ltd in October 2017 where she has since lead the development, manufacture and more recently the exploitation of the PhenoDrive product portfolio.
Want to discuss your project further with the TissueClick team? Contact us
